In the body, L-arginine acts as a building block for nitric oxide(NO synthase)
The original weight management approval was based on the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program, which enrolled over 4,500 participants without diabetes
In the phase 3 SLIMMER trial published in The Lancet Diabetes & Endocrinology last year, ecnoglutide achieved weight loss of 15.1% at 48 weeks, with no evidence of a plateauing of effect, along with improvements in waist circumference, blood pressure, lipid profile, HbA1c, fasting glucose, and insulin levels
For couples: Many couples explore PT-141 together it can be a thoughtful way to address differences in desire that affect intimacy
Improved insulin function and reduced blood glucose variability